1200 PAGE MILL RD, PALO ALTO, CA
Financial Results, Press Release
Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
Kodiak Sciences Enters Underwriting Agreement for Public Offering of Shares
Submission of Matters to a Vote of Security Holders
Annual Report to Security Holders
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Amended Schedule 13G - Ownership Report
Correspondence
Submission Upload